Form 8-A12B Immuneering Corp

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

IMMUNEERING CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Delaware		26-1976972
(State of incorporation or organization)		(I.R.S. Employer Identification No.)
245 Main Street, Second Floor, Cambridge, MA		02142
(Address of principal executive offices)		(Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be so registered		Name of each exchange on which each class is to be registered
Class A Common Stock, $0.001 par value per share		The Nasdaq Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ¨

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-257791

 

Securities to be registered pursuant to Section 12(g) of the Act: None.

 

 

 

Item 1.

Description of Registrant’s Securities to be Registered.

 

The description of the Class A Common Stock, par value $0.001 per share, of Immuneering Corporation (the “Registrant”) under the heading “Description of Capital Stock” in the prospectus included in the Registrant’s Registration Statement on Form S-1 (File No. 333-257791), as initially filed with the Securities and Exchange Commission on July 9, 2021, including exhibits, and as may be subsequently amended (the “Registration Statement”), is hereby incorporated by reference. Any form of prospectus that constitutes part of the Registration Statement and is subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.

 

Item 2.

Exhibits.

 

Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: July 26, 2021

 

	IMMUNEERING CORPORATION
	By:	/s/ Benjamin J. Zeskind
		Benjamin J. Zeskind, Ph.D.
		President and Chief Executive Officer

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Arthrex Wins Both Gold and Silver Medals at 2024 Edison Awards
• Illinois Speaker Chris Welch Recommended by Proviso Township Democratic Organization to Serve as Committeeman
• Averill & Reaney Attorneys at Law Unveils New Community Recovery Initiative